Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 75 citing articles:

Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation
Fei Ren, Qian Fei, Kun Qiu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 34
Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1
Jian Gao, Yong-Qiang Ao, Ling-Xian Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 51
CircSV2b participates in oxidative stress regulation through miR-5107-5p-Foxk1-Akt1 axis in Parkinson's disease
Quancheng Cheng, Jianwei Wang, Man Li, et al.
Redox Biology (2022) Vol. 56, pp. 102430-102430
Open Access | Times Cited: 47
MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?
Han Yang, Yufang Liu, Long‐Qing Chen, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 877-877
Open Access | Times Cited: 38
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 23
The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 13
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
Jessica Konen, Haoyi Wu, Don L. Gibbons
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 520-536
Closed Access | Times Cited: 8
Inhibition of CARM1‐Mediated Methylation of ACSL4 Promotes Ferroptosis in Colorectal Cancer
Shengjie Feng, Zejun Rao, Jiakun Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 21
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Dian Xiong, Lu Zhang, Zhi‐Jun Sun
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?
Calogera Claudia Spagnolo, Francesco Pepe, Giuliana Ciappina, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104332-104332
Open Access | Times Cited: 7
Exosome therapeutics for non-small cell lung cancer tumorigenesis
Niloufar Orooji, Manouchehr Fadaee, Tohid Kazemi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Role of miR‑181a‑5p in cancer (Review)
Junxin Li, Jing Shen, Yueshui Zhao, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 4
Open Access | Times Cited: 14
Circ6834 suppresses non-small cell lung cancer progression by destabilizing ANHAK and regulating miR-873-5p/TXNIP axis
Maoye Wang, Xiaoge Ding, Xinjian Fang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1
Jing Lü, Huita Wu, Ping Zhan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Engineered EVs from LncEEF1G - overexpressing MSCs promote fibrotic liver regeneration by upregulating HGF release from hepatic stellate cells
Jiebin Zhang, Xiaotong Qiu, Yunguo Lei, et al.
Experimental & Molecular Medicine (2025)
Open Access
Transcriptomic profiling reveals mechanism, therapeutic potential, and prognostic value of cancer stemness characteristic in nasopharyngeal carcinoma
Jinwei Chen, Runnan Shen, Jiangquan Zhu, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Role of the circRNA/miRNA/mRNA axis in Renal Cell Carcinoma: from gene regulation to metabolism and immunity
Zhengjun Xu, Yurong Dong, Kun Cui, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112183-112183
Open Access
CircRNAs regulate the crosstalk between inflammation and tumorigenesis: The bilateral association and molecular mechanisms
Javeria Qadir, Shuo‐Yang Wen, Hui Yuan, et al.
Molecular Therapy (2022) Vol. 31, Iss. 6, pp. 1514-1532
Open Access | Times Cited: 20
Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
Man Wang, Lijie Zhu, Xiaoxu Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Non‑coding RNA: A promising diagnostic biomarker and therapeutic target for esophageal squamous cell carcinoma (Review)
Longze Zhang, Yanyan Wang, Jianmei Gao, et al.
Oncology Letters (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 4
PRMT3 and CARM1: Emerging Epigenetic Targets in Cancer
Jiaoti Huang, Bei-Ning Qiao, Yixin Yuan, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 4
Open Access
Circular RNA circ‐TNRC6B inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by regulating the miR‐452‐5p/DAG1 axis
Ruiyu Xu, Pingan Ding, Xiaoru Zhao, et al.
Molecular Oncology (2023) Vol. 17, Iss. 7, pp. 1437-1452
Open Access | Times Cited: 10
ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3
Yong-Qiang Ao, Jian Gao, Chun Jin, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e007766-e007766
Open Access | Times Cited: 9
DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma
Weina Fan, Ying Xing, Yan Shi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Cancer Cell Secreted Legumain Promotes Gastric Cancer Resistance to Anti-PD-1 Immunotherapy by Enhancing Macrophage M2 Polarization
Xu Pei, Shilong Zhang, Bai‐Quan Qiu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 951-951
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top